About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tsc22d3tm1.2Efmd
targeted mutation 1.2, Eric F Morand
MGI:5515630
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
ot1
Tsc22d3tm1.2Efmd/Y Not Specified MGI:5515720


Genotype
MGI:5515720
ot1
Allelic
Composition
Tsc22d3tm1.2Efmd/Y
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tsc22d3tm1.2Efmd mutation (0 available); any Tsc22d3 mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system

immune system
N
• LPS-treated mice induce normal serum levels of TNF, IL1B and IL6
• in vitro thioglycollate-induced peritoneal macrophages secrete normal levels of TNF, IL1B and IL6
• mice exhibit normal response to glucocorticoid treatment
• modest increase in the ratio of CD4+ to CD8+ T cells in the spleen
• mice treated with cutaneous ovalbumin exhibit increased response including increased lymph node T cell IFNgamma and IL17A production compared with wild-type mice
• from lymph node T cell in mice treated with cutaneous ovalbumin
• from lymph node T cell in mice treated with cutaneous ovalbumin or mBSA
• in response to methylated bovine serum albumin (mBSA) within increased antigen-induced T cell activation (measured by proliferation and IFNgamma release) in lymph node cells
• however, arthritis severity induced by mBSA or K/BxN is normal

hematopoietic system
• modest increase in the ratio of CD4+ to CD8+ T cells in the spleen





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory